샘플 요청 목록

 카트 문의
시장보고서
상품코드
1534059

미생물 제품 시장

Microbial Products
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 250 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 미생물 제품 시장은 2030년까지 2,472억 달러에 달할 전망

2023년에 1,932억 달러로 평가된 세계의 미생물 제품 시장은 분석 기간 2023년부터 2030년까지 CAGR 3.6%로 성장할 전망이며, 2030년에는 2,472억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 박테리아 유형 제품은 CAGR 4.4%로 성장을 지속하고, 분석 기간 종료 시 1,287억 달러에 도달할 것으로 예측됩니다. 곰팡이 유형 제품 부문의 성장률은 분석 기간 동안 CAGR 3.2%로 추정됩니다.

미국 시장은 526억 달러로 추정, 중국은 CAGR 7.0%로 성장 예측

미국의 미생물 제품 시장은 2023년 526억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 520억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023년부터 2030년까지 CAGR은 7.0%로 전망됩니다. 다른 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.1%와 2.7%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 1.9%로 성장할 것으로 예측됩니다.

세계의 미생물 제품 시장-주요 동향 및 촉진요인 요약

미생물 제품은 박테리아, 균류, 조류를 포함한 미생물에 의해 생산되는 다양한 물질을 포함하고, 의약품, 농업, 음식, 환경 관리 등 다양한 산업에서 응용되고 있습니다. 의약품에서는 항생제, 백신, 효소 등의 미생물 제품이 질병 예방 및 치료에 중요한 역할을 합니다. 예를 들어, 처음 발견된 항생제인 페니실린은 페니실륨 곰팡이에서 파생됩니다. 그 밖에도 유전자 조작된 박테리아를 이용하여 제조되는 인슐린이나 진균의 대사산물로 만들어져 콜레스테롤 수치를 낮추는데 사용되는 스타틴 등 주목할 만한 미생물 제품이 있습니다. 농업 분야에서 미생물 제품은 바이오 비료와 바이오 농약으로 사용되어 식물의 성장을 가속하고 해충과 질병으로부터 작물을 보호합니다. 예를 들어, 리조븀 박테리아는 콩과 식물의 질소 고정을 촉진하고 바실러스 튜링겐시스(Bt)는 해충에 효과적인 독소를 생산합니다. 화학 비료와 살충제를 대체하는 환경 친화적인 이러한 농약은 지속가능성과 환경에 미치는 영향의 감소로 인기를 얻고 있습니다.

음식 및 음료 산업은 또한 요구르트, 치즈, 빵, 맥주, 와인 등 다양한 발효 식품 및 식품 생산에 미생물 제품에 크게 의존하고 있습니다. 유산균, 사카로마이세스, 아스페르길루스 등의 미생물에 의한 발효는 이들 제품의 영양가, 풍미, 보존성을 높입니다. 또한, 아밀라아제, 프로테아제, 리파아제 등의 미생물 효소는 식감, 맛, 소화성을 향상시키기 위해 식품 가공에 널리 이용되고 있습니다. 환경관리에서는 유출유, 중금속, 유기폐기물 등의 오염물질을 분해하여 오염사이트를 정화하는 바이오레메디에이션 프로세스에 미생물 제품을 채용하고 있습니다. 슈도모나스와 파넬로카에테 크리소스포륨 등의 미생물은 유해물질의 분해와 생태계의 균형 회복에 도움이 됩니다. 게다가, 재생가능한 바이오매스 미생물 발효로부터 에탄올과 바이오디젤과 같은 바이오연료를 생산하는 것은 화석연료에 대한 의존성을 줄이고 온실가스 배출을 완화시키는 유망한 해결책입니다.

미생물 제품 시장의 성장은 몇 가지 요인에 의해 발생합니다. 생명공학 및 유전공학의 진보로 미생물 공정을 산업용도에 이용 및 최적화하는 능력이 대폭 강화되어 보다 효율적이고 비용효율적인 생산방법을 가져오고 있습니다. 지속가능하고 환경친화적인 제품에 대한 수요가 증가함에 따라 농업, 식품생산, 환경관리에 미생물 솔루션의 채택을 추진하고 있습니다. 또한 소비자의 선호도는 천연 제품과 유기 제품으로 이동하고 있으며 미생물 기반 식품 및 농업 투입물 시장을 밀어 올리고 있습니다. 또한 항생제 내성균 증가는 미생물 유래의 신규 항생제와 치료제의 연구 개발을 촉진하고 있습니다. 생명공학과 환경의 지속가능성에 대한 연구에 대한 정부의 이니셔티브와 자금 지원은 시장 성장에 더욱 탄력을 줍니다. 이러한 동향이 진화를 계속하고 있는 가운데 미생물 제품 시장은 기술의 진보, 규제 당국의 지원, 지속가능성 문제에 대한 소비자의 의식이 높아짐에 따라 대폭적인 확대가 전망되고 있습니다.

조사 대상 기업 예(총 86건)

  • Ajinomoto Health & Nutrition North America, Inc.
  • bioMerieux SA
  • Genomatica, Inc.
  • GlaxoSmithKline plc
  • JH Biotech, Inc.
  • Kan biosys
  • Koninklijke DSM NV
  • Kyowa Hakko Bio Co., Ltd.
  • Lesaffre Group
  • Merck KGaA
  • Microbial Discovery Group, LLC
  • Novartis AG
  • Pfizer Inc.
  • Sanofi Group
  • Valent BioSciences LLC

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

AJY 24.08.27

Global Microbial Products Market to Reach US$247.2 Billion by 2030

The global market for Microbial Products estimated at US$193.2 Billion in the year 2023, is expected to reach US$247.2 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2023-2030. Bacterial Type Products, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$128.7 Billion by the end of the analysis period. Growth in the Fungi Type Products segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$52.6 Billion While China is Forecast to Grow at 7.0% CAGR

The Microbial Products market in the U.S. is estimated at US$52.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$52.0 Billion by the year 2030 trailing a CAGR of 7.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Microbial Products Market - Key Trends and Drivers Summarized

Microbial products encompass a diverse range of substances produced by microorganisms, including bacteria, fungi, and algae, which have applications across various industries such as pharmaceuticals, agriculture, food and beverages, and environmental management. In pharmaceuticals, microbial products such as antibiotics, vaccines, and enzymes play a crucial role in disease prevention and treatment. For instance, penicillin, the first antibiotic discovered, is derived from the Penicillium mold. Other notable microbial products include insulin, which is produced using genetically engineered bacteria, and statins, which are derived from fungal metabolites and used to lower cholesterol levels. In agriculture, microbial products are used as biofertilizers and biopesticides to promote plant growth and protect crops from pests and diseases. Rhizobium bacteria, for example, enhance nitrogen fixation in legumes, while Bacillus thuringiensis (Bt) produces toxins that are effective against insect pests. These environmentally friendly alternatives to chemical fertilizers and pesticides are gaining popularity due to their sustainability and reduced environmental impact.

The food and beverage industry also heavily relies on microbial products for the production of various fermented foods and beverages, such as yogurt, cheese, bread, beer, and wine. Fermentation, driven by microorganisms like Lactobacillus, Saccharomyces, and Aspergillus, enhances the nutritional value, flavor, and shelf life of these products. Moreover, microbial enzymes such as amylases, proteases, and lipases are widely used in food processing to improve texture, taste, and digestibility. In environmental management, microbial products are employed in bioremediation processes to clean up contaminated sites by breaking down pollutants like oil spills, heavy metals, and organic waste. Microorganisms such as Pseudomonas and Phanerochaete chrysosporium are instrumental in degrading toxic substances and restoring ecological balance. Additionally, the production of biofuels, such as ethanol and biodiesel, from microbial fermentation of renewable biomass offers a promising solution to reduce dependency on fossil fuels and mitigate greenhouse gas emissions.

The growth in the microbial products market is driven by several factors. Advances in biotechnology and genetic engineering have significantly enhanced the ability to harness and optimize microbial processes for industrial applications, leading to more efficient and cost-effective production methods. The increasing demand for sustainable and eco-friendly products is propelling the adoption of microbial solutions in agriculture, food production, and environmental management. Consumer preferences are also shifting towards natural and organic products, boosting the market for microbial-based foods and agricultural inputs. Furthermore, the rise in antibiotic-resistant bacteria is driving research and development of novel microbial-derived antibiotics and therapeutics. Government initiatives and funding for research in biotechnology and environmental sustainability are providing further impetus to market growth. As these trends continue to evolve, the microbial products market is poised for substantial expansion, driven by technological advancements, regulatory support, and growing consumer awareness of sustainability issues.

Select Competitors (Total 86 Featured) -

  • Ajinomoto Health & Nutrition North America, Inc.
  • bioMerieux SA
  • Genomatica, Inc.
  • GlaxoSmithKline plc
  • JH Biotech, Inc.
  • Kan biosys
  • Koninklijke DSM N.V.
  • Kyowa Hakko Bio Co., Ltd.
  • Lesaffre Group
  • Merck KGaA
  • Microbial Discovery Group, LLC
  • Novartis AG
  • Pfizer Inc.
  • Sanofi Group
  • Valent BioSciences LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Microbial Products - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Biotechnology and Genetic Engineering Propel Market Growth
    • Increasing Demand for Sustainable and Eco-Friendly Products Expands Addressable Market Opportunity
    • Consumer Shift towards Natural and Organic Products Drives Adoption
    • Rise in Antibiotic-Resistant Bacteria Spurs Development of Novel Microbial-Derived Therapeutics
    • Enhanced Production Methods Using Microbial Processes Strengthen Business Case for Microbial Products
    • Growing Use of Biofertilizers and Biopesticides in Agriculture Generates Demand
    • Innovations in Microbial Fermentation Techniques Accelerate Adoption in Food and Beverage Industry
    • Expansion of Bioremediation Applications Throws Spotlight on Environmental Management Solutions
    • Development of Microbial Enzymes for Industrial Applications Drives Market Growth
    • Increasing Production of Biofuels from Microbial Fermentation Expands Market Opportunities
    • Technological Advancements in Microbial Strain Improvement Enhance Product Efficacy
    • Integration of Microbial Products in Waste Management Solutions Expands Addressable Market
    • Enhanced Nutritional Value and Flavor Profiles of Fermented Foods Drives Consumer Adoption
    • Expanding Applications of Microbial Products in Pharmaceuticals Spurs Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microbial Products Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Microbial Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Bacterial Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Bacterial Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Bacterial Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Fungi Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Fungi Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Fungi Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Viral Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Viral Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Viral Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pharmaceuticals Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Biotechnology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • JAPAN
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • CHINA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • EUROPE
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Microbial Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • FRANCE
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • GERMANY
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Microbial Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • INDIA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Microbial Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Microbial Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • AFRICA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제